Medical device licence · 71326 · Class 4
SEPRAGEL ENT
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed May 8, 2006; ended October 29, 2010. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 71326
- Licence holder
- Genzyme CorporationCambridge, Massachusetts, United States
- Risk class
- Class IV (highest risk)
- Licence type
- Single Device
- First licensed
- May 8, 2006
- Ended
- October 29, 2010
- Devices covered
- 1
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- SEPRAGEL ENT
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.